Impact of pretreatment dihydropyrimidine dehydrogenase genotype-guided fluoropyrimidine dosing on chemotherapy associated adverse events.
Wigle TJ, Povitz BL, Medwid S, Teft WA, Legan RM, Lenehan J, Nevison S, Panuganty V, Keller D, Mailloux J, Siebring V, Sarma S, Choi YH, Welch S, Winquist E, Schwarz UI, Kim RB.
Wigle TJ, et al. Among authors: winquist e.
Clin Transl Sci. 2021 Jul;14(4):1338-1348. doi: 10.1111/cts.12981. Epub 2021 Feb 23.
Clin Transl Sci. 2021.
PMID: 33620159
Free PMC article.